LyoDx

18/05/2026

We are pleased to announce that TB-SIX has been successfully registered with the Medicines and Healthcare products Regulatory Agency (MHRA) as a UK IVD medical device.

This registration marks a significant regulatory milestone, reflecting LyoDx's self-declaration of conformity with the applicable safety and performance requirements under the UK medical device regulatory framework.

TB-SIX is intended for use as:

• an aid in the diagnosis of active tuberculosis (TB) disease; and
• an aid in monitoring the effectiveness of anti-tuberculosis treatment in individuals with confirmed active TB.

Achieving MHRA registration reflects the rigorous technical, quality and clinical work undertaken by the LyoDx team, including the development of a comprehensive technical documentation package and alignment with UK regulatory expectations.

We are proud of this step forward and look forward to progressing TB-SIX into clinical and research settings in the UK and beyond.

To find out more about TB-SIX, visit our website: https://lyodx.com/

24/04/2026

We had a great few days in Munich at ESCMID Global 2026, connecting with collaborators, catching up on the latest research and sharing progress from our TB-SIX assay. Thank you to all who met with us, see you next year in Stockholm!

Swipe for highlights 👉

And visit our website to view the poster: https://lyodx.com/resources

ESCMID

17/04/2026

Wishing everyone a great first day at ESCMID Global. Looking forward to seeing what is new across infectious diseases and to connecting with colleagues over the coming days.

Please reach out for any last-minute meetings at [email protected]

07/04/2026

Jennie and Alex are looking forward to ESCMID Global next week and to meeting collaborators, partners and colleagues.

If you’ll be there and would like to connect, please get in touch at [email protected].

24/03/2026

Today is World TB Day. 🌍🫁

Ending tuberculosis (TB) will take more than ambition or new technologies alone.

We’ve shared a short blog reflecting on why multi-sector collaboration is essential for developing diagnostics that are not only innovative, but adoptable and impactful in the settings where TB burden is highest.

Read the blog here: https://lyodx.com/blog/f/why-collaboration-is-key-for-innovation-in-tb-diagnostics

Yes! We can end TB. Led by innovation. Powered by collaboration. 🤝

World TB Day – 24th March

06/03/2026

Lyophilisation (freeze-drying) is an effective way to stabilise diagnostic reagents, reducing reliance on cold-chain logistics and making tests easier to transport, store and use.

In our new blog, we explore:
• how lyophilisation works
• what can be freeze-dried in molecular assays
• why it matters for global access to diagnostics

Read the full article: https://lyodx.com/blog/f/freeze-how-lyophilisation-is-expanding-access-to-diagnostics

Diagnostic tools are often reviewed in terms of sensitivity, specificity and time-to-result. Less discussed is the practical question of how these tests are transported, stored and ultimately used across vastly different...

16/02/2026

What is TB-SIX?

Our TB-Signature Immune eXpression assay (TB-SIX) is a multiplex PCR laboratory assay that measures mRNA transcripts in whole blood in response to TB infection.

Based on the RISK6 signature and currently for Research Use Only, LyoDx has simplified the workflow by developing an all-in-one lyophilised solution.

👉 For more information and Frequently Asked Questions about TB-SIX visit:
https://lyodx.com/tb-six

Stable Science • Simplified Workflows • Confident Decisions

06/02/2026

LyoDx will be attending ESCMID Global 2026 in Munich this April. 🇩🇪

We’re looking forward to connecting with peers in microbiology, infectious diseases and diagnostics.

If you’re attending and would like to meet, please drop us an email at [email protected].

15/12/2025

It's been a month since launching LyoDx and it wouldn’t have been possible without the support of our friends across the diagnostics community.

Huge thank you to all our new followers, we're excited to share our journey with you!

🌐 www.lyodx.com

24/11/2025

We had a great few days launching LyoDx at The World Conference on Lung Health in Copenhagen last week. Thanks to everyone who came to speak to us on the stand.

If we missed you, get in touch via our website below.

www.LyoDx.com

17/11/2025

Thrilled to share that our website is now live.

Discover how LyoDx is simplifying diagnostics through lyophilisation technology.

Visit us at http://lyodx.com

Stable Science • Simplified Workflows • Confident Decisions